ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,626.02
      0.54%
      US Tech 100
      18,986.40
      0.30%
      Dow Jones
      41,393.78
      0.72%
      Brent Oil
      71.825
      0.00%
      Bitcoin
      60,202.94
      0.32%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      09/10/20248:00AMGlobeNewswire Inc.New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves Time-In-Range (TIR) and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/03/20244:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in Upcoming September Investor ConferencesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/03/20248:00AMGlobeNewswire Inc.New Secondary Analysis of Phase 3 Data Demonstrates that INPEFA® (Sotagliflozin) Benefited Heart Failure Patients Regardless of Diabetes DurationNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/16/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/15/20244:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/13/20248:30AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Strategic Repositioning to Drive Value and Growth of Commercial PortfolioNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/12/20248:40AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/12/20248:39AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/07/20248:00AMGlobeNewswire Inc.Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Disease Among Three Lexicon-Sponsored Presentations at the 2024 Annual Conference of the Association of Diabetes Care & Education SpecialistsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20249:37AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/02/20247:06AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/01/20244:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/29/20245:44PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/29/20245:31PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/25/20248:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 1, 2024NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/16/20248:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA ResubmissionNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/15/20248:00AMGlobeNewswire Inc.New Published Data Highlights Potential Cost-Savings of INPEFA® (sotagliflozin) for Heart FailureNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/08/20245:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/08/20245:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/08/20245:26PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/08/20249:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/08/20249:15AMGlobeNewswire Inc.Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and DirectorNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/21/20248:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/19/20248:00AMGlobeNewswire Inc.Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes AssociationNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/18/20248:00AMGlobeNewswire Inc.Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of CardiologyNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/14/20248:00AMGlobeNewswire Inc.Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes AssociationNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/29/20247:30AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/16/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/14/20245:05PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX

      Your Recent History

      BOV
      ITUBU371
      ITUBU371 Ex:35,42
      BOV
      N1DA34M
      NASDAQ
      Delayed Upgrade Clock